It should be noted that although lowering the upper limit of ALT for health may increase the inclusion of non-NAFLD patients, having a normal ALT level does not guarantee the absence of NAFLD. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.